Guru Ownership Trend
Guru Analysis for ADMA Biologics, Inc. (ADMA)
ADMA Biologics, Inc. (ADMA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $82.13 M.
Top institutional holders include Stanley Druckenmiller and Terry Smith.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $16.94 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 196.4%. Conversely, Steven Cohen reduced exposure by 87.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for ADMA Biologics, Inc. (ADMA)
Major holders include Stanley Druckenmiller ($23.3 M), Terry Smith ($13.81 M), Cliff Asness ($12.77 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 7.5 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $16.94 M, with 3 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited ADMA. The total reported sell value was $36.39 M.
Yes, 1 managers opened new positions in ADMA, and 2 increased their existing holdings. The total reported buy value was $19.44 M.
